लोड हो रहा है...
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223
BACKGROUND: Bone metastasis is the most frequent complication in prostate cancer patients and associated outcome remains fatal. Radium223 (Rad223), a bone targeting radioisotope improves overall survival in patients (3.6 months vs. placebo). However, clinical response is often followed by relapse an...
में बचाया:
| में प्रकाशित: | BMC Cancer |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7325060/ https://ncbi.nlm.nih.gov/pubmed/32600282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07084-w |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|